SCHEMBL4886954

SCHEMBL4886954

CC(C)(C)C(=O)OCCOCCOCCOCCOC(=O)C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PRKCA P17252 1/20 0.42
ALDH1A1 P00352 3/20 0.41
TSHR P16473 3/20 0.41
TP53 P04637 2/20 0.41
HIF1A Q16665 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP4F2 P78329 2/20 0.36
CYP4A11 Q02928 2/20 0.36
THRB P10828 2/20 0.35
ELANE P08246 3/20 0.33
SERPINE1 P05121 1/20 0.33
MEN1 O00255 1/20 0.32
GBA1 P04062 1/20 0.32
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
BTN3A1 O00481 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1640972 1.00 POLB (0.44) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL4885829 1.00 POLB (0.44) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL5021535 1.00 POLB (0.44) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL4258156 0.92 POLB (0.48) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL12392875 0.91 POLB (0.40) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL408792 0.91 MEN1 (0.48) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL16021740 0.91 ALDH1A1 (0.56) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL12972548 0.91 POLB (0.40) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL13686744 0.91 ALDH1A1 (0.40) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL408378 0.91 ALDH1A1 (0.40) POLBGAANPSR1PRKCAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404258-B2 External preparation for the skin SHISEIDO COMPANY, LTD. (JP) 2013-03-26 US disclosed
US-8404258-B2 External preparation for the skin SHISEIDO COMPANY, LTD. (JP) 2013-03-26 US disclosed
US-20080293811-A1 External preparation for the the skin SHISEIDO COMPANY, LTD. (JP) 2008-11-27 US disclosed
US-20080293811-A1 External preparation for the the skin SHISEIDO COMPANY, LTD. (JP) 2008-11-27 US disclosed
EP-1430905-B1 SKIN TREATMENT COMPOSITION SHISEIDO CO LTD (JP) 2007-11-14 EP disclosed
EP-1430905-B1 SKIN TREATMENT COMPOSITION SHISEIDO CO LTD (JP) 2007-11-14 EP disclosed
EP-1430905-A4 EXTERNAL PREPARATION FOR THE SKIN SHISEIDO CO LTD (JP) 2006-06-14 EP disclosed
US-20040197361-A1 External preparation for the skin SHISEIDO COMPANY, LTD. (JP) 2004-10-07 US disclosed
US-20040197361-A1 External preparation for the skin SHISEIDO COMPANY, LTD. (JP) 2004-10-07 US disclosed
CN-1535162-A External preparation for skin ������������ʽ���� 2004-10-06 CN disclosed
EP-1430905-A1 EXTERNAL PREPARATION FOR THE SKIN SHISEIDO COMPANY LIMITED (JP) 2004-06-23 EP disclosed
EP-1430905-A1 EXTERNAL PREPARATION FOR THE SKIN SHISEIDO COMPANY LIMITED (JP) 2004-06-23 EP disclosed
WO-2003026698-A1 EXTERNAL PREPARATION FOR THE SKIN SHISEIDO COMPANY, LTD. (JP) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040197361-A1 External preparation for the skin CUTA, DDOST, DSG1 POLB 830/4885GAA 1411/4885NPSR1 935/4885
US-20080293811-A1 External preparation for the the skin CUTA, DDOST, DSG1 POLB 912/4885GAA 1285/4885NPSR1 979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.